New paper argues current exercise and protein guidelines aim too low for healthy ageing.

Cells have surface receptors that couple to proteins and other molecules to initiate or inhibit certain behaviors. Typically, the number of these receptors increases as the cell matures, but researchers have now identified that one receptor influences cell behavior much earlier than previously thought and appears to help trigger the cell differentiation process to form neurons. 

A tiny parasite-carrying tick is posing an outsized threat to Missouri’s cattle. Now, researchers at the University of Missouri are stepping in to protect the state’s $4 billion cattle industry by tracking different ways the American dog tick spreads a deadly disease known as bovine anaplasmosis.

River experts say new satellite technology holds the promise of protecting water quality around the world. In a paper published in the journal Nature Water hydrology experts from around the world explained how scientists can use new tools such as satellite remote sensing to study water quality and the health and stressors of all of the world’s rivers.

CAMBRIDGE, Mass. / HONG KONG — June 17, 2026 — Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with the completion of first-in-human dosing in the Phase I study of ISM8969. ISM8969 is a potentially best-in-class, orally available, brain-penetrant small-molecule inhibitor of the NLRP3 inflammasome being developed to treat chronic neuroinflammation and central nervous system (CNS) disorders, including Parkinson’s disease.

Neurosurgeons at University of Michigan Health completed the first-in-human implant of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking. The clinical trial will focus on the device’s long-term safety, and it will also assess whether the BCI can restore the participant’s communication through synthesized text and speech, and help them control a computer.

Neurosurgeons at University of Michigan Health completed the first-in-human implant of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking. The clinical trial will focus on the device’s long-term safety, and it will also assess whether the BCI can restore the participant’s communication through synthesized text and speech, and help them control a computer.